On March 23, 2025, genetic testing company 23andMe announced it filed for bankruptcy — sparking a firestorm of articles and online posts advising consumers to delete their personal data in order to ...

Kayte Spector-Bagdady, is an associate professor of obstetrics and gynecology at the University of Michigan. As soon as the genetic testing company 23andMe filed for bankruptcy on March 23, 2025, ...

23andMe filed for Chapter 11 bankruptcy on Sunday. The company says no changes will be made to how it stores, manages or protects customer data up until the sale of its assets is finalized. 23andMe ...

32,785 people played the daily Crossword recently. Can you solve it faster than others?32,785 people played the daily Crossword recently. Can you solve it faster than others?

Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.

Genetic testing service 23andMe said on March 23 that it filed for Chapter 11 bankruptcy protection — an effort to keep the company running while reorganizing its debts. The company is navigating an ...

Regeneron Pharmaceuticals announced on Monday that it will acquire "substantially all" of genetic testing company 23andMe's assets. The pharmaceutical company said it won the court-supervised auction ...

Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she co-founded nearly 20 years ago, has received the court greenlight. That means Wojcicki’s nonprofit TTAM Research Institute will ...

Genetic testing firm 23andMe is set to be acquired by drug company Regeneron Pharmaceuticals following its bankruptcy in March, the companies announced on Monday, May 19. Regeneron purchased the ...

Genetic testing company 23andMe filed for bankruptcy in March. Regeneron Pharmaceuticals on Monday announced plans to purchase genetic testing company 23andMe for $256 million. The New York-based ...